Nastech Pharmaceutical

Nastech Pharmaceutical Company Inc. is a Formulation Science specialty company that utilizes biophysics, physical chemistry and pharmacology to bridge the gap between drug discovery and drug optimization.Nastech’s proprietary Systemic Transnasal Absorption Technology (STA-T™), Paracellular Transport System (PTS™), and Junction Activator Technology (JAT™) provide rapid assessment of the merits of a drug compound for intranasal drug delivery. The Company has a diverse product portfolio across multiple therapeutic areas, including products targeted for the treatment of sexual dysfunction, pain management, cancer and hepatic illnesses, growth deficiency and multiple sclerosis. Nastech is broadening applications for its technology through an aggressive pre-clinical and clinical program involving the intranasal delivery of large-molecule drugs.

Contact Details: 3830 Monte Villa Parkway Bothell Washington 98021 United States of America Tel: 425-908-3600 Fax: 425-908-3650 Email: ir@nastech.com WWW: www.nastech.com/

Loading...

Recent Publications by Nastech Pharmaceutical:
Development of Calcitonin Salmon Nasal Spray: similarity of peptide formulated in chlorobutanol compared to benzalkonium chloride as preservative. The similarity of an intranasal salmon calcitonin (sCT) employing...	20th February, 2009	Nastech Pharmaceutical Company, Inc, Bothell, Washington 98021, USA.	J Pharm Sci. 2009 Oct;98(10):3691-706. DOI Direct Link
Identification of tight junction modulating lipids. Tight junctions (TJs) play an important role in regulating paracellular...	13th February, 2009	Nastech Pharmaceutical Company, Inc, Bothell, Washington, USA.	J Pharm Sci. 2009 Feb;98(2):606-19. DOI Direct Link
Intranasal administration of acetylcholinesterase inhibitors. This short review outlines the rationale, challenges, and opportunities...	3rd February, 2009	Nastech Pharmaceutical Company Inc, 3830 Monte Villa Parkway, Bothell, WA	BMC Neurosci. 2008 Dec 10;9 Suppl 3:S6. DOI Direct Link
Discovery of tight junction modulators: significance for drug development and delivery. Tight junction biology has many important applications, from improving...	20th September, 2008	Nastech Pharmaceutical Company, Inc., 3830 Monte Villa Parkway, Bothell,	Drug Discov Today. 2008 Mar;13(5-6):261-7. Epub 2008 Feb 20. DOI Direct Link
A potential treatment for pandemic influenza using siRNAs targeting conserved regions of influenza A. BACKGROUND: The recent emergence of avian H5N1 influenza virus has led to...	22nd April, 2008	Nastech Pharmaceutical Company, Inc., 3830 Monte Villa Parkway, Bothell,	Expert Opin Biol Ther. 2008 Mar;8(3):299-313. DOI Direct Link
→View more Nastech Pharmaceutical research publications.

BioNews Results for Nastech Pharmaceutical:
Pharmaceuticals : EmailWire.Com SEO Press Release Distribution Services and PharmaNewsWire.Com Present Free Ph	TMC Net:  Nov 14 2009 6:23PM Matching: pharmaceutical
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments	Montana's News Station:  Nov 14 2009 5:59PM Matching: pharmaceutical
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments	KSLA:  Nov 14 2009 4:28PM Matching: pharmaceutical
Teva Pharmaceutical Industries Limited - Financial And Strategic Analysis Review - New Report Published	OfficialSpin:  Nov 14 2009 10:17AM Matching: pharmaceutical
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments	Pharmacy Choice:  Nov 14 2009 5:46AM Matching: pharmaceutical
Promote your company here: BioNewsCast - Press Release Distribution	→View more Nastech Pharmaceutical news.

Nastech Pharmaceutical Clinical Trials:
A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects

Nastech Pharmaceutical Patents:
US Patent No.	Title
7329725	Phage displayed Trp cage ligands
6436950	Nasal delivery of apomorphine
6225343	Compositions and methods comprising morphine gluconate
5874450	Intranasal formulations for promoting sleep and method of using the same
5770618	Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
→View more Nastech Pharmaceutical patents.

Nastech Pharmaceutical (NSTK) Financial information Links from Barchart
NSTK Quote from from Barchart.com
NSTK Chart from from Barchart.com
NSTK Profile from from Barchart.com
NSTK Opinion from from Barchart.com
→View more Nastech Pharmaceutical finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 491 times since April 2007, the link to the organisation's website has been followed 88 times

Recent Search Terms used to find this page: nastech pharmaceutical | nastech pharmaceutical | nastech pharmaceutical | nastech financial history | nastech 2009 | nastech pharmaceutical logo | .

Search for more companies in Bothell

Search for more companies in Washington

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Nastech Pharmaceutical